SCHEMBL4854510

SCHEMBL4854510

COc1ccccc1-c1ccc(OCCN(C)C)c(C(=O)/C=C/c2ccccc2CN2CCN(C)CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 4/20 0.44
NFE2L2 Q16236 4/20 0.44
HDAC3 O15379 4/20 0.40
HDAC4 P56524 4/20 0.40
HDAC1 Q13547 4/20 0.40
HDAC7 Q8WUI4 4/20 0.40
HDAC2 Q92769 4/20 0.40
HDAC10 Q969S8 4/20 0.40
HDAC11 Q96DB2 4/20 0.40
HDAC8 Q9BY41 4/20 0.40
HDAC6 Q9UBN7 4/20 0.40
HDAC9 Q9UKV0 4/20 0.40
HDAC5 Q9UQL6 4/20 0.40
SLC6A9 P48067 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
HTR7 P34969 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6142473 1.00 KEAP1 (0.44) KEAP1NFE2L2HDAC3HDAC4HDAC1
SCHEMBL4854515 0.91 HDAC3 (0.47) KEAP1NFE2L2HDAC3HDAC4HDAC1
SCHEMBL4854720 0.91 SLC6A9 (0.44) KEAP1NFE2L2HDAC3HDAC4HDAC1
SCHEMBL4846166 0.91 SLC6A9 (0.44) KEAP1NFE2L2HDAC3HDAC4HDAC1
SCHEMBL4850209 0.86 HTR7 (0.46) KEAP1NFE2L2SLC6A9MAOBHTR7
SCHEMBL4852586 0.86 HTR7 (0.46) KEAP1NFE2L2SLC6A9MAOBHTR7
SCHEMBL4846414 0.85 SLC6A9 (0.42) KEAP1NFE2L2SLC6A9KDM4EALDH1A1
SCHEMBL4852855 0.85 SLC6A9 (0.42) KEAP1NFE2L2SLC6A9KDM4EALDH1A1
SCHEMBL4849755 0.83 KDM4E (0.41) KEAP1NFE2L2SLC6A9MAOAMAOB
SCHEMBL4854750 0.83 KDM4E (0.41) KEAP1NFE2L2SLC6A9MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed